NeuroMetrix Inc (NURO)

NASDAQ

Currency in USD

4.328

-0.072(-1.64%)

Real-time Data·18:49:43

Fair Value

Unlock Value

Day's Range

4.328

4.381

52 wk Range

2.660

4.730

NeuroMetrix (NURO) Income Statement & Profits

Assess the NeuroMetrix Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Advanced Income Statement

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

7.38

8.25

8.26

5.9

3.03

Total Revenues Growth

aa.aa

-20.43%

+11.87%

+0.03%

-28.52%

-48.61%

Cost Of Revenues

aa.aa

2.13

2.33

2.51

1.95

1.32

Gross Profit

aa.aa

5.25

5.92

5.75

3.95

1.71

Gross Profit Growth

aa.aa

+26.75%

+12.8%

-2.89%

-31.35%

-56.65%

Gross Profit Margin %

aa.aa

71.15%

71.75%

69.65%

66.89%

56.42%

Other Operating Expenses, Total

aa.aa

7.34

8.21

10.49

11.1

9.91

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-43.74%	+11.73%	+27.85%	+5.78%	-10.69%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.72	2.39	3.08	2.58	1.28
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5.62	5.81	7.42	8.52	8.63
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-2.09

-2.28

-4.74

-7.15

-8.2

Operating Income Growth

aa.aa

+76.5%

-9.06%

-107.55%

-50.82%

-14.68%

EBIT Margin %

aa.aa

-28.39%

-27.68%

-57.43%

-121.18%

-270.43%

Net Interest Expenses

aa.aa

0.33

0.26

0.05

Net Interest Expenses Growth

aa.aa

+10,222.44%

-20.93%

-81.79%

Interest Expense, Total

aa.aa

Interest And Investment Income

aa.aa

0.33

0.26

0.05

Other Non Operating Expenses, Total

aa.aa

EBT, Excl. Unusual Items

aa.aa

-2.09

-2.28

-4.42

-6.89

-8.15

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-2.09

-2.28

-4.42

-6.53

-7.81

EBT, Incl. Unusual Items Growth

aa.aa

+44.55%

-9.05%

-93.59%

-47.84%

-19.55%

EBT, Incl. Unusual Items Margin

aa.aa

-28.36%

-27.64%

-53.5%

-110.64%

-257.38%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-2.09

-2.28

-4.42

-6.53

-7.81

Minority Interest

aa.aa

Net Income

aa.aa

-2.09

-2.28

-4.42

-6.53

-7.81

Net Income Growth

aa.aa

+44.55%

-9.05%

-93.59%

-47.84%

-19.55%

Net Income Margin %

aa.aa

-28.36%

-27.64%

-53.5%

-110.64%

-257.38%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-2.09

-2.28

-4.42

-6.53

-7.81

Basic EPS - Continuing Operations

aa.aa

-5.55

-3.57

-4.97

-6.27

-3.96

Basic EPS - Continuing Operations Growth

aa.aa

+82.19%

+35.68%

-39.04%

-26.21%

+36.76%

Diluted EPS - Continuing Operations

aa.aa

-5.55

-3.57

-4.97

-6.27

-3.96

Diluted EPS - Continuing Operations Growth

aa.aa

+82.19%

+35.68%

-39.18%

-26.08%

+36.76%

Basic Weighted Average Shares Outstanding

aa.aa

0.38

0.64

0.89

1.04

1.97

Diluted Weighted Average Shares Outstanding

aa.aa

0.38

0.64

0.89

1.04

1.97

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-2

-2.21

-4.69

-7.1

-8.11

EBITDA Growth

aa.aa

+77.19%

-10.14%

-112.49%

-51.22%

-14.26%

EBITDA Margin %

aa.aa

-27.17%

-26.76%

-56.84%

-120.24%

-267.33%

EBIT

aa.aa

-2.09

-2.28

-4.74

-7.15

-8.2

* In Millions of USD (except for per share items)

FTSE 100

8,415.25

+7.81

+0.09%

DAX

22,236.41

+171.90

+0.78%

Euro Stoxx 50

5,156.05

+41.07

+0.80%

S&P 500

5,504.37

+19.60

+0.36%

Nikkei 225

35,705.74

+666.59

+1.90%

Dow Jones

39,991.08

-102.32

-0.26%

FTSE 100 Futures

8,429.50

+10.5

+0.12%

Market Movers

Name	Last	Chg. %	Vol.
NatWest Group	474.60	+1.26%	59.67M
BP	364.45	+0.62%	49.61M
HALEON	377.50	+0.24%	47.94M
HSBC	834.00	+0.81%	37.46M
Rio Tinto PLC	4,550.0	-1.37%	4.27M
Reckitt Benckiser	4,633.0	-1.00%	3.97M
AstraZeneca	10,400.0	-0.42%	2.80M

Name	Last	Chg. %	Vol.
Viridien	49.335	+10,601.74%	620.00
Fincantieri	11.12	+2,038.46%	16.23K
Ensurge Micropower ASA	1.260	+479.54%	7.48K
Alpha Bank	2.199	+317.27%	2.00
National Bank of Greece	9.709	+249.62%	984.00
MFE MEDIAFOREUROPE NV B	4.198	+247.23%	4.30K
Heijmans	43.74	+156.09%	6.66K

Name	Last	Chg. %	Vol.
Sporttotal	0.023	-99.26%	63.62K
Mynaric	0.72	-96.47%	842.00
Idex ASA	0.0401	-95.68%	368.56K
Rapid Nutrition	0.0059	-91.57%	1.49K
Rockwool B	286.30	-89.04%	5.63K
Wolfspeed	3.15	-88.25%	172.70K
REC Silicon	2.12	-86.16%	54.64K

Trending Stocks

Name	Last	Chg. %	Vol.
Greatland Gold	12.900	-1.23%	66.47M
Rolls-Royce Holdings	755.24	+2.73%	12.81M
John Wood	17.28	-4.43%	24.43M
Legal & General	237.60	+0.38%	20.21M
Catenai	0.4650	-11.43%	100.77M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaa Aaaaa A Aa	364.45	+37.28%	500.32
Aaa Aa Aaa Aa	4,633.0	+30.68%	6,054.40
Aaaaaa	157.35	+30.37%	205.14
Aaaaaaaaaaa	4,550.0	+25.57%	5,713.43
A Aaaaaaaaaaa	1,899.00	+25.51%	2,383.43
Aaaaaa A	3,141.0	+20.73%	3,792.13
Aa Aaaaa Aaaa	10,400.0	+20.08%	12,488.32

Name	Last	Upside	Fair Value
Aaaaa Aaaaa A Aa	364.45	+37.28%	500.32
Aaa Aa Aaa Aa	4,633.0	+30.68%	6,054.40
Aaaaaa	157.35	+30.37%	205.14
Aaaaaaaaaaa	4,550.0	+25.57%	5,713.43
A Aaaaaaaaaaa	1,899.00	+25.51%	2,383.43
Aaaaaa A	3,141.0	+20.73%	3,792.13
Aa Aaaaa Aaaa	10,400.0	+20.08%	12,488.32

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

NeuroMetrix Inc (NURO)

NeuroMetrix (NURO) Income Statement & Profits

Trending Stocks